another letter in the scheme of things- further

To DATE: 27/03/2012
PLACE:RAICHUR
The Registrar,
Rajiv Gandhi University Of Health Sciences,Karnataka
Bangalore,
Subject:Immediate attention for correction & inclusion of subjects for pharm D (PB) course-reg
Through: The Principal, N.E.T Pharmacy College Raichur.
Respected Sir,
We are the Pharm-D(Post Baccalautreate) students(2010-2013) pursuing the course from NET Pharmacy College Raichur under RGUHS.
According to Pharm-D (Post Baccalaureate) regulations 2008 mentioned in RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, Karnataka, the scheme of Examination for Pharm-D(Post Baccalaureate) Course, given in page no. 4,the subject Hospital and Community pharmacy(serial no.1.5) is already mentioned to be included in the First Year(Fourth year of Pharm-D course). But instead the above subject, Biopharmaceutics and pharmacokinetics(serial no. 4.5) has been included, as given in table (First year Post baccalaureate-Fourth year of Pharm-D course) on page no.2.
This is to inform you that, at our B.Pharm syllabus under various Universities we didn’t had subjects of Hospital & Community Pharmacy, and Pathophysiology. These subjects are the basic and fundamental subjects for a Pharm-D(PB) course, upon which other subjects are based e.g.: Pharmacotherapeutics I,II,and III are related with Pathophysiology. Though these subjects are included in the Pharm D(6yr-regular) university syllabus in 2nd year, where as these are not included in Pharm D(PB) RGUHS syllabus. Sir, this is to bring to your notice that these above subjects are very important for an aspirant clinical pharmacist to understand the basics and are the essence of the Pharm D(PB) course.
All of us students of Pharm D(PB) also had not studied either of these two subjects or one or none in our B.Pharm syllabus under our respective universities.
Sir, without having these 2 basic clinically oriented subjects (1.Hospital&Community Pharmacy) and 2. Pathophysiology our course wont be valid and valued.
We request you to kindly consider our appeal and make suitable amendments in the existing Pharm.D(PB) Syllabus by adding these 2 basic subjects, effective from this academic year, so that we all Pharm D(PB) students may cover all the required core subjects under our syllabus which will enable us to be at par with Pharm D(6yr-regular) students who already have these subjects in their syllabus. This may also enable us to be eligible for appearing in competitive exams at international level. Hence we shall get better jobs and opportunities globally.
We hope our request will be considered favorably and implemented at the earliest.
Thanking You,
Yours Sincerely,
Pharm D(Post Baccalaureate) students,
2010-13 batch
N.E.T PC Raichur.
ENCLOSURES: 1. List of Pharm D(PB) students of N.E.T Pharmacy College, who completed B.Pharm . from various universities (including RGUHS) with subjects not studied in their B.Pharm.
2. The remarks of our faculty on addition of subjects in Pharm D(PB) syllabus. . 3. FPGEC bulletin 2011. Copy to: 1. Dean, Faculty Of Pharmacy, RGUHS, Bangalore. . 2. Chairman; BOS, Faculty Of , RGUHS, Bangalore.

Pharmacist and Pharmacotherapist

Pharmacists are healthcare/pharmacare professionals focused on the safe dispensing, management, and education regarding medications. Pharmacotherapists are specialized pharmacists who work directly with physicians to design, monitor, and adjust individualized, complex medication therapies to optimize patient outcomes, often in clinical or hospital settings. 

Key Differences:

• Role Focus: Pharmacists ensure medication safety, provide counseling, and dispense prescriptions. Pharmacotherapists focus on therapeutic drug management, disease state management, and optimizing drug regimens.
• Work Setting: Pharmacists often work in community pharmacies or hospital settings. Pharmacotherapists are generally specialized clinicians found in hospitals or specialized clinics.
• Specialization: While all pharmacists have a PharmD, a pharmacotherapist often holds board certification (e.g., Board Certified Pharmacotherapy Specialist - BCPS).
• Patient Interaction: Both interact with patients, but pharmacotherapists have a more direct role in therapeutic decision-making alongside doctors. 

Shared Goals:
Both aim to maximize therapeutic benefits, ensure safe medication use, prevent drug-related problems, and enhance overall quality of life for patients. 

DEA number

A DEA number (DEA Registration Number) is an identifier assigned to a health care provider (such as a physician, optometrist, ], dentist, or veterinarian) by the United States Drug Enforcement Administration allowing them to write prescriptions for controlled substances.

After completion of Pharm D(PB) in India and after successfully passing entrance exam by CPC in India again, will the indian pharmacist is supposed to appear for entrance exam FPGEE /NAPLEX in USA, so as a DEA number is issued to him by USA ? 

Yes, a pharmacist with a PharmD can obtain a DEA number, but only if their state of practice grants them prescriptive authority and they meet specific legal requirements. By default, holding a PharmD does not automatically mean you possess or need a DEA registration. 

The rules vary depending on your scope of practice:

• Clinical Pharmacists (Restricted): In states that allow pharmacists to prescribe or manage medication therapies (such as managing controlled substances in clinics or the VA health system), a pharmacist can register with the DEA as a mid-level practitioner. There are only about 11 states (including California, Washington, New Mexico, and Ohio) that broadly authorize this for qualifying clinical pharmacists. 
• Retail Pharmacists (Usually No): Retail or community pharmacists typically do not have or require their own personal DEA numbers to verify, process, or dispense controlled substances. They rely on the DEA numbers of the prescribing doctors (or hospitals) to verify prescriptions. 

Difference between Pharm-D and M. D Pharmacologist

A Doctor of Pharmacy (Pharm.D.) is a clinical degree focused on patient medication management, dispensing, and direct care. An M.D. Pharmacologist is a medical doctor who specializes in the research, development, and bodily effects of drugs, usually working in laboratories or clinical trials. 

The differences span distinct roles in the healthcare system, areas of expertise, and daily responsibilities:

Core Distinctions

• Doctor of Pharmacy (Pharm.D.)
  • Focus: Clinical practice, patient counseling, and therapeutic drug monitoring.
  • Primary Role: They ensure the safe and effective use of prescribed medications, review for drug interactions, and calculate dosages. They can hold prescriptive authority in some regions or work collaboratively with physicians to manage therapy.
  • Work Environment: Hospitals, retail pharmacies, clinics, and long-term care facilities.
  • Training: Typically a 6-year doctoral program prioritizing patient-care rotations, pharmacokinetics, and therapeutics. 
• M.D. Pharmacologist
  • Focus: The biomedical science of drugs, how they affect living organisms, and new drug development.
  • Primary Role: Conducting clinical trials, designing new pharmacological therapies, and evaluating the safety and efficacy of novel medications. They are legally licensed physicians who have completed medical school and specialized residency training in pharmacology and who have prescribing authority.
  • Work Environment: Pharmaceutical companies, research laboratories, academic institutions, and hospitals.
  • Training: 4-5 years of medical school (MBBS/M.D.), followed by an M.D. in Pharmacology or a post-doctoral fellowship, blending medical practice with heavy scientific research. 

Summary

If you think of the pharmaceutical pipeline, Pharm.D.s focus on the application—how to safely get the right medication to the right patient. M.D. Pharmacologists focus on the discovery and science—studying how new or existing drugs work and testing them at the molecular and clinical trial levels. 

**An M.D. (Medical Doctor) Pharmacologist** has full, independent prescribing authority, while a **Pharm.D. (Doctor of Pharmacy)** has highly limited, dependent prescribing authority.

Here is exactly how their training and legal rights break down:

### 1. M.D. Pharmacologist (Full Authority)

An M.D. pharmacologist is a fully licensed medical doctor who went to medical school, completed clinical residency, and then chose to specialize in pharmacology (the scientific study of how drugs interact with the human body).

 * **Prescribing Power:** **Full and Independent.** Because they hold an M.D. (or D.O.), they have the broadest legal right to diagnose illnesses and independently prescribe all classes of medications, including controlled substances (Schedules II–V).

 * **Their Role:** They often split their time between seeing patients clinically and working in research labs, academic centers, or pharmaceutical companies designing and testing new drug therapies.

### 2. Pharm.D. (Limited/Collaborative Authority)

A Pharm.D. is a clinical pharmacist. They are medication experts who complete a four-year professional pharmacy doctorate to understand drug compositions, interactions, dosages, and safe distribution.

 * **Prescribing Power:** **Highly Restricted.** Generally, pharmacists cannot independently diagnose diseases or write standard prescriptions from scratch. However, their scope of practice has expanded under specific legal frameworks:

   * **Collaborative Practice Agreements (CPAs):** In many hospitals and clinics, a physician can delegate authority to a Pharm.D. This allows the pharmacist to manage, adjust, or change a patient's medication doses for chronic conditions (like diabetes or hypertension) after the doctor makes the initial diagnosis.

   * **Statewide Protocols:** Depending on the region (such as specific states in the US), a Pharm.D. may independently prescribe a strict, limited list of urgent public health medications, such as vaccines, hormonal birth control, smoking cessation aids, or opioid reversal medications (Naloxone).

### Summary Comparison

| Metric | M.D. Pharmacologist | Pharm.D. |

|---|---|---|

| **Primary Focus** | Diagnosing patients, treating medical conditions, and scientific drug research. | Ensuring the safe dispensing, proper usage, and clinical management of medications. |

| **Prescribing Authority** | **Independent & Broad** (All major classes of medications). | **Dependent & Limited** (Requires protocols, physician agreements, or specific public health exceptions). |

| **Controlled Substances** | Yes, with a standard DEA registration. | Generally no, unless explicitly structured under rigid clinical collaborative agreements. |

Collaborative Practice Agreement (Clinical) (CPA)

Collaborative Practice Agreement (Clinical)

• What it is: A formal, legally binding document between a pharmacist and a physician (or other healthcare provider).
• Function: It grants the pharmacist expanded clinical privileges—such as the ability to initiate, modify, or discontinue medication therapy and order lab tests—that go beyond standard dispensing roles

A **Collaborative Practice Agreement (CPA)** is a formal, legal document that establishes a professional partnership between a licensed healthcare clinician (most commonly a **Nurse Practitioner (NP)** or a **Clinical Pharmacist**) and a supervising or collaborating **Physician**.

Instead of requiring a physician to sign off on every single patient decision, a CPA defines exactly what medical tasks the clinician can perform independently and when they need to refer back to the physician.

## Core Elements of a CPA

While the exact legal language varies depending on state or local laws, every clinical CPA typically covers four foundational areas:

 * **Scope of Practice:** Specifies the exact clinical services, treatments, and procedures the clinician is authorized to perform.

 * **Prescriptive Authority:** Details which medications, controlled substances, and medical devices the clinician can prescribe, alter, or manage.

 * **Protocols & Guidelines:** Outlines the clinical practice guidelines or evidence-based protocols that will guide patient care decisions.

 * **Supervision & Communication:** Sets rules for how often the chart reviews happen, how the physician can be reached for emergency consultations, and back-up plans when the primary physician is unavailable.

## The Two Most Common Clinical CPAs

### 1. Advanced Practice Registered Nurses (APRNs / NPs)

In many regions, Nurse Practitioners are required by law to have a signed CPA with a physician to practice. The CPA serves as the legal bridge allowing the NP to diagnose illnesses, order diagnostic tests, and prescribe medications within their designated specialty (e.g., Family Practice, Pediatrics).

### 2. Clinical Pharmacists

Often referred to as **Advanced Pharmacy Practice** or **Collaborative Drug Therapy Management (CDTM)**. In this setup, a physician delegates the management of a patient’s drug therapy to a pharmacist.

> **Clinical Example:** A physician diagnoses a patient with Type 2 Diabetes and signs a CPA with the clinic's pharmacist. Under the agreement, the pharmacist can independently order blood tests (like HbA1c), adjust insulin dosages, and start or stop medications to hit the patient's health targets, without needing a new prescription from the doctor each time.

> 

## Why CPAs Matter

 * **Expands Patient Access:** Allows clinics to see more patients efficiently, especially in underserved or rural areas facing doctor shortages.

 * **Optimizes Chronic Care:** Patients with ongoing conditions (hypertension, asthma, diabetes) get highly focused, frequent medication adjustments from specialists like pharmacists or NPs.

 * **Legal Protection:** It clearly defines boundaries, ensuring all practicing clinicians are fully compliant with their local licensing boards and malpractice insurance requirements.

A **Collaborative Practice Agreement (CPA)** is a formal, legal contract between physicians and pharmacists. It delegates specific patient care duties—such as initiating, modifying, or discontinuing medications—to the pharmacist under strict, pre-approved guidelines.

When applied to **refill authorizations** and **prior authorizations (PA)**, a CPA transforms the pharmacist from a traditional dispenser into a clinical partner, dramatically cutting down administrative delays for patients and reducing physician burnout.

## 1. Refill Authorization Under a CPA

In a standard pharmacy setup, when a patient runs out of refills, the pharmacist must send a request to the physician and wait for approval. Under a CPA, the physician delegates the authority to approve these refills directly to the pharmacist, provided specific clinical parameters are met.

### How It Works:

 * **The 12-Month Rule:** CPAs typically grant pharmacists the power to extend maintenance medications for chronic conditions (e.g., diabetes, hypertension) only if the patient has seen their primary care physician within the last 12 months.

 * **Clinical Guardrails:** The pharmacist doesn't just blindly click "approve." They review the Electronic Health Record (EHR) to ensure required lab work (like an HbA1c for diabetes or basic metabolic panels for blood pressure meds) is up to date.

 * **Quantity and Logic Adjustments:** Pharmacists can adjust quantities (e.g., switching from a 30-day supply to a 90-day supply to improve adherence) or perform therapeutic interchanges (e.g., substituting an unavailable brand-name drug for an equivalent generic/formulary option).

 * **Exclusions:** Controlled substances (like opioids or stimulants) and complex specialty drugs (like chemotherapy) are almost always strictly excluded from a pharmacist's autonomous refill authority.

## 2. Prior Authorization (PA) Management Under a CPA

Prior authorization is the administrative process where insurance companies require clinical justification before approving coverage for a drug. It is notoriously time-consuming for clinics. A CPA streamlines this by shifting the burden to the pharmacist.

### How It Works:

 * **Direct EHR Access:** The agreement grants the pharmacist full or partial access to the clinic's EHR.

 * **Autonomy to Substitute:** If a prescribed medication requires a PA, the pharmacist can check the insurance formulary and immediately switch the patient to a preferred, covered alternative within the same therapeutic class—without calling the doctor.

 * **Document Gathering:** If no alternative exists and a PA is absolutely necessary, the pharmacist uses their clinical expertise to gather charts, lab results, and trial histories required by the insurer, submits the paperwork, and tracks the appeal.

 * **Signing Authority:** Depending on state laws and the specific wording of the CPA, the pharmacist may be authorized to sign the PA forms on behalf of the physician's care team.

## Core Components of the Agreement

To be legally binding and effective, the written CPA must explicitly define the scope of the collaboration.

```

+-----------------------------------------------------------------------+

|                       TYPICAL CPA STRUCTURE                           |

+-----------------------------------------------------------------------+

|  1. Authorized Parties     -> Named physicians & licensed pharmacists |

|  2. Scope of Practice     -> Chronic conditions allowed (e.g. COPD)   |

|  3. Protocols & Clinical   -> Up-to-date labs required, dosage tables  |

|  4. Communication Loop     -> Documentation in EHR within 24–48 hours  |

|  5. Oversight & Review     -> Annual audit of pharmacist decisions     |

+-----------------------------------------------------------------------+

```

> **The Communication Loop is Critical:** Every time a pharmacist authorizes a refill or modifies a script to clear a PA, they are legally required to document it in the shared patient record (EHR) within a specified window (usually 24 to 48 hours). The physician remains the ultimate authority and can cancel or override any pharmacist action.

> 

## Why This Team Model Works

| For the Physician | For the Pharmacist | For the Patient |

|---|---|---|

| **Saves Time:** Frees up hours spent on daily faxed refill requests and insurance phone calls. | **Utilizes Expertise:** Allows the pharmacist to practice at the top of their clinical license. | **Zero Delays:** Eliminates the "waiting on the doctor" lag at the pharmacy counter. |

| **Reduces Burnout:** Shifts administrative burdens to a trusted clinical peer. | **Integrates Care:** Embeds the pharmacist directly into the primary care team. | **Better Adherence:** Reduces the risk of skipped doses due to lapsed refills. |

*Note: The exact legal boundaries of a CPA are dictated by state law. Some states allow broad, independent collaborative authority, while others require highly restrictive, patient-specific protocols.*

A **Collaborative Practice Agreement (CPA)** is a formal, legal document that establishes a structured partnership between licensed physicians (or other prescribers) and clinical pharmacists.

At its core, a CPA expands a pharmacist's traditional scope of practice. Instead of just dispensing medications and calling the doctor for every minor adjustment, the physician formally delegates specific patient care duties to the pharmacist under mutually agreed-upon protocols.

## 🔑 Key Functions Allowed Under a CPA

When a CPA is active, the pharmacist can perform **Collaborative Drug Therapy Management (CDTM)**. Depending on state laws and the specifics of the contract, this generally includes:

 * **Adjusting Drug Therapy:** Initiating, modifying, or discontinuing medications (e.g., altering insulin doses for a diabetic patient).

 * **Authorizing Refills:** Managing and extending ongoing maintenance prescriptions without needing to contact the physician's office for every renewal.

 * **Ordering & Interpreting Lab Tests:** Monitoring bloodwork (like HbA1c for diabetes, INR for blood thinners, or lipid panels for cholesterol) to ensure the drugs are working safely.

 * **Physical Assessments & Screening:** Taking blood pressure, conducting point-of-care testing (e.g., strep or flu swabs), and reviewing a patient’s complete health profile.

## 📋 Standard Components of a CPA Contract

To be legally valid, a CPA must be highly structured and detailed. It typically includes:

| Section | What It Explicitly Defines |

|---|---|

| **Authorized Parties** | The exact names and license numbers of the collaborating physician(s) and pharmacist(s). |

| **Scope & Protocol** | The specific chronic conditions (e.g., hypertension, asthma, diabetes) and medication classes the pharmacist is allowed to manage. |

| **Notification Rules** | Clear instructions on *when* and *how* the pharmacist must notify the physician about changes made to a patient's regimen. |

| **Documentation** | A mandate on how interventions must be recorded in the patient’s medical chart or electronic health record (EHR). |

| **Timeframe & Review** | An expiration date (typically 1 to 2 years) requiring both parties to review, update, and renew the agreement. |

## 🏆 Why Do Providers Use Them?

The main driver behind CPAs is moving toward **team-based care** to address physician shortages and the rising numbers of patients with chronic diseases.

> **The Main Benefit:** Efficiency. Phone calls, faxes, and emails regarding prescription clarifications occur multiple times a day in a standard practice. A CPA cuts out this time-consuming back-and-forth, allowing the physician to focus on complex diagnoses while the pharmacist optimizes ongoing medication therapy.

> 

### Clinical Impact

Studies show that integrating a pharmacist via a CPA dramatically improves patient outcomes. For example, patients enrolled in CPAs routinely achieve better blood pressure control, improved blood sugar stability (lower A1C values), and higher medication adherence rates.